Evidence map›Paper›PMID 39733204›Full record

ArticleInternational journal of bipolar disorders2024

Dynamics of affect modulation in neurodevelopmental disorders (DynAMoND) - study design of a prospective cohort study.

Maximilian Bayas, Tobias D Kockler, Josep Antoni Ramos-Quiroga, Silvia Muñoz Caller, Christian Fadeuilhe, Giovanni de Girolamo, Laura Iozzino, Miriam D'Addazio, Jan Haavik, Anne Halmøy and 14 more

Abstract read
In one paragraph

Article in International journal of bipolar disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The emotional side of adult ADHD.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Maximilian BayasDepartment for Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt-Goethe University, Frankfurt am Main, Germany. bayas@med.uni-frankfurt.de.
Tobias D KocklerDepartment for Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt-Goethe University, Frankfurt am Main, Germany.
Josep Antoni Ramos-QuirogaDepartment for Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
Silvia Muñoz CallerDepartment for Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
Christian FadeuilheDepartment for Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
Giovanni de GirolamoEpidemiological and Evaluation Psychiatry Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Laura IozzinoEpidemiological and Evaluation Psychiatry Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Miriam D'AddazioEpidemiological and Evaluation Psychiatry Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Jan HaavikK.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, University of Bergen, Bergen, Norway.
Anne HalmøyDivision of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Karin Schiøler HellumDivision of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Joakim Njaastad KolleDivision of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Berge OsnesDepartment of Clinical Psychology, University of Bergen, Bergen, Norway.
Astri J LundervoldDepartment of Biological and Medical Psychology, University of Bergen, Bergen, Norway.
Nader PerroudDepartment of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Roland HaslerDepartment of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Mélanie Teixeira De AlmeidaDepartment of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Ulrich W Ebner-PriemerMental mHealth Lab, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Sharmili Edwin ThanarajahDepartment for Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt-Goethe University, Frankfurt am Main, Germany.
Carmen SchiweckDepartment for Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt-Goethe University, Frankfurt am Main, Germany.
Silke MaturaDepartment for Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt-Goethe University, Frankfurt am Main, Germany.
Jonathan ReppleDepartment for Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt-Goethe University, Frankfurt am Main, Germany.
Andreas ReifDepartment for Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt-Goethe University, Frankfurt am Main, Germany.
Mareike AichholzerDepartment for Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt-Goethe University, Frankfurt am Main, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAttention-deficit/hyperactivity disorder (ADHD) is a common neuro-developmental disorder that often persists into adulthood. Moreover, it is frequently accompanied by bipolar disorder (BD) as well as borderline personality disorder (BPD). It is unclear whether these disorders share underlying pathomechanisms, given that all three are characterized by alterations in affective states, either long or short-term. BD is characterized by infrequent but intense mood shifts, while ADHD and BPD involve more dynamic emotional fluctuations. It is yet to be determined whether these disorders represent distinct phenomena or different points on a spectrum of affective dysregulation.

methodsThis study seeks to distinguish the emotional dysregulation of BPD, ADHD, and BD by using digital phenotyping, a measurement burst electronic-diary method with different sampling rates, and accelerometry to measure participants' activity. Our study will include 480 participants aged 14 to 50 (120 each from BPD, ADHD, BD, and healthy control groups) from five European sites. Participants' smartphones will provide continuous data on their digital phenotypes, i.e., by indicators of physical activity and communication, for one year, along with daily evening ratings of mood and sleep. Moreover, five intensive measurement periods of five days each, called measurement bursts, will occur throughout the year, with electronic diaries asking participants to report on mood, self-esteem, impulsivity, life events, social interactions, and dysfunctional behaviors ten times a day. Moreover, participants will wear activity sensors during the five measurement bursts. Statistical analysis aims to identify whether affective dysregulation aspects share or differ across disorders. Specifically, data analysis aims to investigate the differences in parameters of affect fluctuation such as attractor strength and variability between disorders and to test the association of genetic risk factors for psychiatric disorders and resilience factors with critical parameters of affect modulation. DISCUSSION: The results of this study offer the potential to link patients' external exposures with their affective state, reduce misdiagnosis, and determine the best timing for therapeutic interventions. Potential limitations of the study include insufficient recruitment of patients and drop-outs due to various protocol violations.

trial registrationStudy code: DRKS00028917, registered 27.07.2022, https://drks.de/search/de/trial/DRKS00028917 .

Indexed as

Affective stateAmbulatory assessmentAttention-deficit/hyperactivity disorderBipolar disorderBorderline personality disorderDigital phenotypingEmotion dysregulation

Identifiers

PMID39733204
PMCPMC11682027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.